GLP-1 / GIP / Amylin: class map and YMYL-safe language
Abstract GLP-1, GIP and Amylin often appear mixed up in the same narrative ("everything is incretin"), but they are different axes with different targets
January 22, 2026
STATUS: Open File.
Live archive. Subtitle + summary in PubMed mode — Technical summary, without noise.
Read More »
DAC vs No-DAC: continuous exposure, pulses and desensitisation (high-level)
ABSTRACT In the S157 ecosystem, "DAC vs No-DAC" is not a technical detail: it's a signal philosophy. The same molecule
January 22, 2026
Metabolic Control: The Pharmacodynamic War between Semaglutide and Tirzepatide
Comparative efficacy analysis based on SURPASS trials. The impact of dual agonism (GIP/GLP-1) on glycaemic control and body composition versus first-generation monotherapy. Verdict on the risk/benefit ratio.
19 December 2025
EN 
PT 
FR 
ES 
DE 
IT 
PL